Department of Pathology

NYC Viral Hepatitis Research Symposium – May 24



Montefiore will co-sponsor, with the NYC Department of Health and Mental Hygiene, the 2018 New York City Viral Hepatitis Research Symposium. The all-day event will be held on Thursday, May 24, at Rockefeller University. It will bring together approximately 200 medical providers, laboratory directors, community service providers, policy-makers and other stakeholders from the New York City metro area. Local research and innovative projects related to viral hepatitis prevention, management and treatment will be showcased. The theme is “Equity in Prevention and Treatment.” 

Amy S. Fox, MD, MS, Director of Montefiore Einstein Department of Pathology’s Virology Laboratories, will be the event emcee. Yitzchak Goldstein, MD, Assistant Director of Virology Laboratories, together with Matthew J. Akiyama, MD, MSc, of the Montefiore Einstein Department of Medicine (DOM)’s Divisions of Infectious Diseases and General Internal Medicine, and Jonathan M. Schwartz, MD, a specialist in liver diseases and liver transplantation in the DOM’s Division of Hepatology, are members of the symposium advisory board.
In 2014, New York State implemented the nation’s first law mandating that HCV screening must be offered to people born between 1945 and 1965. Two years ago, Montefiore’s Virology Lab went one step further and established the reflex testing protocol for hepatitis C, using a unique algorithmic testing model. This greatly reduces turnaround time for reporting and expedites clinicians’ ability to begin treatment for affected patients. Montefiore was the first in New York State to implement HCV reflex testing, and we have the highest compliance rate in NYC, which allows for multiple clinically necessary tests to be performed on a single patient specimen.
The symposium will feature experts on liver disease presenting throughout the day. Montefiore will host a panel
where Drs. Goldstein, Akiyama and Schwartz will discuss the algorithmic model of HCV reflex testing as well as other innovative models of hepatitis C care.
The event is free of charge. All interested laboratory directors and supervisors, clinicians and researchers are encouraged to attend. Advance registration is strongly recommended. Tickets are available at:
Click here to log in